Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: Immunohistochemical studies and mutation analysis of the p53 gene

Pathology Research and Practice

Volumn 202, Issue 10, 2006, Pages 751-756

  Sato, Katsuaki ^a   Ueda, Yoshimichi ^a   Shikata, Hiroo ^a   Katsuda, Shogo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bronchioloalveolar carcinoma; Cytokeratin 20; Cytokeratin 7; p53 gene; Thyroid transcriptional factor 1

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; MUCIN; PROTEIN P53; THYROID TRANSCRIPTION FACTOR 1; UVOMORULIN;

ADULT; ARTICLE; CASE REPORT; CELL GROWTH; CELL TYPE; CELLULAR DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; CYTOPLASM; EXON; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOGENESIS; LUNG LOBE; LUNG RESECTION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; THORAX RADIOGRAPHY; TUMOR CELL; TUMOR VOLUME;

EID: 33748575592     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.07.002     Document Type: Article

References (18)

1. Awaya H., Takeshima Y., Amatya V.J., Ishida H., Yamasaki M., Kohno N., and Inai K. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma. Pathol. Int. 55 (2005) 14-18
2. Awaya H., Takeshima Y., Yamasaki M., and Inai K. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Am. J. Clin. Pathol. 121 (2004) 644-653
3. Clayton F. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates. Cancer 57 (1986) 1555-1564
4. Colby T.V., Ohori P., Jambhekar N.A., et al. Adenocarcinoma. In: Travis W.D., Brambilla E., Muller-Hermelink H.K., and Harris C.C. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart (2004), IARC Press, Lyon pp. 35-44
5. Goldstein N.S., and Thomas M. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Am. J. Clin. Pathol. 116 (2001) 319-325
6. Hidaka N., Nagao T., Asoh A., Kondo Y., and Nagao K. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. Mod. Pathol. 11 (1998) 1039-1045
7. Koga T., Hashimoto S., Sugio K., Yoshino I., Mojtahedzadeh S., Matsuo Y., Yonemitsu Y., Sugimachi K., and Sueishi K. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. Clin. Cancer Res. 7 (2001) 1730-1738
8. Lau S.K., Desrochers M.J., and Luthringer D.J. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. Mod. Pathol. 15 (2002) 538-542
9. Maeshima A., Sakamoto M., and Hirohashi S. Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K-ras gene mutation. Virchows Arch. 440 (2002) 598-603
10. Marchetti A., Pellegrini S., Bertacca G., Buttitta F., Gaeta P., Carnicelli V., Nardini V., Griseri P., Chella A., Angeletti C.A., and Bevilacqua G. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. J. Pathol. 184 (1998) 240-246
11. Moriya Y., Niki T., Yamada T., Matsuno Y., Kondo H., and Hirohashi S. Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 91 (2001) 1129-1141
12. Ohori N.P., and Santa Maria E.L. Cytopathologic diagnosis of bronchioloalveolar carcinoma: does it correlate with the 1999 World Health Organization definition?. Am. J. Clin. Pathol. 122 (2004) 44-50
13. Saad R.S., Liu Y.L., Han H., Landreneau R.J., and Silverman J.F. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Hum. Pathol. 35 (2004) 3-7
14. Sakurai H., Dobashi Y., Mizutani E., Matsubara H., Suzuki S., Takano K., Shindo S., and Matsumoto M. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment. Ann. Thorac. Surg. 78 (2004) 1728-1733
15. Sarantopoulos G.P., Gui D., Shintaku P., Hong L., Wang Y.Y., Yap C.S., and Fishbein M.C. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation. Arch. Pathol. Lab. Med. 128 (2004) 406-414
16. Shah R.N., Badve S., Papreddy K., Schindler S., Laskin W.B., and Yeldandi A.V. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Hum. Pathol. 33 (2002) 915-920
17. Terasaki H., Niki T., Matsuno Y., Yamada T., Maeshima A., Asamura H., Hayabuchi N., and Hirohashi S. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am. J. Surg. Pathol. 27 (2003) 937-951
18. Yamasaki M., Takeshima Y., Fujii S., Kitaguchi S., Matsuura M., Tagawa K., and Inai K. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung. Pathol. Int. 50 (2000) 778-785